Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€99.78

€99.78

-0.140%
-0.14
-0.140%
€115.00
 
17:44 / Tradegate WKN: SYM999 / Name: Symrise / Stock / Chemicals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Symrise AG is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Symrise

sharewise wants to provide you with the best news and tools for Symrise, so we directly link to the best financial data sources.

News

EQS-News: Symrise sees successful start into the 2024 fiscal year: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23742/Symrise_Logo.svg.png
EQS-News: Symrise sees successful start into the 2024 fiscal year
EQS-News: Symrise sees successful start into the 2024 fiscal year
EQS-News: Symrise AG again raises sales significantly in 2023 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23742/Symrise_Logo.svg.png
EQS-News: Symrise AG again raises sales significantly in 2023
EQS-News: Symrise AG again raises sales significantly in 2023
EQS-News: Press Release: Dr Jean-Yves Parisot assumes CEO position from Dr Heinz-Jürgen Bertram: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23742/Symrise_Logo.svg.png
EQS-News: Press Release: Dr Jean-Yves Parisot assumes CEO position from Dr Heinz-Jürgen Bertram
EQS-News: Press Release: Dr Jean-Yves Parisot assumes CEO position from Dr Heinz-Jürgen Bertram
EQS-Adhoc: Symrise AG: CEO change at Symrise AG: Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23742/Symrise_Logo.svg.png
EQS-Adhoc: Symrise AG: CEO change at Symrise AG: Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot
EQS-Adhoc: Symrise AG: CEO change at Symrise AG: Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot
EQS-Adhoc: Symrise AG: Updated sales and profitability development 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23742/Symrise_Logo.svg.png
EQS-Adhoc: Symrise AG: Updated sales and profitability development 2023
EQS-Adhoc: Symrise AG: Updated sales and profitability development 2023